This paper argues the convenience of considering multiple databases in order to obtain a reliable set of scientific indicators
in case of fields that includes a variety of disciplines. With this aim we analyse the Spanish scientific output in Plant
Sciences regarding mainstream literature covered by SCI database and that published in domestic journals covered by ICYT database.
This method allows us to obtain two different profiles of research. These results clearly underly the need to consider these
databases jointly, thus avoiding potential inaccuracies induced by the use of the SCI as the only information source to be
considered for the assessment of research.
The use of indicators based on the analysis of the scientific literature cited in patent documents is proposed for the evaluation
of biomedical research. A study carried out on several groups of researchers working in universities, public research centers,
and hospitals, has shown that an important percentage of Spanish scientists have authored publications that are cited in US
patents in the field of Biotechnology. The study and analysis of those cites allows a evaluation of the flow of knowledge
generated by the different groups of scientists towards the development of technologies, and to learn on the relationship
between the characteristics of the cited publications and the frequency they are cited in the patents. The results obtained
avail the use of new indicators based on the cites in patents to perform a more complete evaluation of the published research
related with Biotechnology and Biomedicine, both at the level of research institutions and individual scientists.
To determine the capability and resources of the Spanish R & D system to produce knowledge useful for the Biotechnology industries, an analysis of indicators derived from published work, scientific papers cited in US patents and inventions patented, has been carried out. The results show that the number of publications compares well with that of other European countries. The visibility of those publications seems evident as about two thirds of the authors studied have been cited in patents assigned to foreign enterprises, but very few of them have applied for patents. This is analysed in connection with the existing policies.
Authors:Esther García-Carpintero, Begoña Granadino and Luis Plaza
This paper analyses the nationalities of the editorial board members of the top 20 journals (according to their impact factor
in the ISI Journal Citation Report, Science Edition 2005) serving 15 scientific disciplines. A total of 281 journals were
analysed (some journals crossed disciplinary boundaries) and 10,055 of their editorial board members were identified. Some
53% of board members were from the United States. Europe provided 32%, with the United Kingdom making the greatest contribution
(9.8%). The analysis of scientific output by nationality in these journals showed a significant correlation, in all disciplines,
with the representation of the corresponding nations on the editorial boards. The composition of editorial boards may therefore
provide a useful indicator for measuring a country’s international scientific visibility. The present results should be taken
into account in the design of national policies with the aim of enhancing the presence of a country’s most prestigious scientists
on the editorial boards of the main international journals.
Authors:Armando Albert, Begoña Granadino and Luis Plaza
An evaluation of the Spanish CSIC performance in Biotechnology, as compared with those of the French CNRS and the Italian
CNR, has been carried out to determine the balance between the generation of scientific knowledge and the transfer of technology.
This study shows a high scientific productivity mostly in journals with moderate impact factor, a low generation of patents
and an insufficient transfer of knowledge to the Spanish companies. Other indicators confirm the existence of competitive
human resources in biotechnological research producing scientific knowledge of interest for the development of patents and
that cooperates successfully at European level.